ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

ACS President Lawrence Emphasizes Prevention Gains Since 1971

April 10, 1992

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995

In Brief: Curran Moves From Fox Chase To Jefferson; Groundbreaking From UNC Lineberger Center

December 2, 1994

Cancer Mortality By County For 1950-69 Now Available From GPO; Price-$9

April 26, 1974

Researchers Find 16 Gene Variants Linked to Colorectal Cancer Using CRCgene Database

September 28, 2012